G1SK34:BVMF
Gsk Plc Bdr
R$57.96
0.00%
(0.00) 1 دن
15 اپریل, 4:48:53 PM GMT -3 · BRL
search
تمام علامات
1 دن
5 دن
1 ماہ
6 ماہ
YTD
1 سال
5 سال
زیادہ سے زیادہ
| علامت | قیمت | تبدیلی | % تبدیلی |
|---|
insights_autoG1SK34 کے لیے سرفہرست بصیرتیں تخلیق کی جا رہی ہیں...
مارکیٹ کی سرمایہ کاری
۸۳٫۴۳ ارب
اوسط والیوم
۱۳٫۰۰
والیوم
۰٫۰۰
52 ہفتے میں اعلی
R$63.24
52 ہفتے کا کم
R$39.98
بقایہ شیئرز
۴٫۰۶ ارب
ملازمین کی تعداد
۶۷ ہزار
خبریں اور کہانیاں
ویب پر موجود ذرائع سے
Traders Union
·
16 گھنٹے پہلے
£2,085 resistance keeps GSK stock flat
Stock Titan
·
21 گھنٹے پہلے
GSK (GSK) repurchases 965,671 shares under ongoing buyback programme
Yahoo Finance
·
1 دن پہلے
GSK (GSK) Earnings Expected to Grow: Should You Buy?
Stock Titan
·
2 دنوں پہلے
GSK (GSK) repurchases 330,000 shares as treasury stock, 6.41% now in treasury
پروفائل
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
Gsk Plc Bdr کے بارے میں
AI مواد میں غلطیاں شامل ہو سکتی ہیں۔ مزید جانیں